Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

NASDAQ:EGRX

Overview | Financials
Company Name Eagle Pharmaceuticals, Inc.
Symbol EGRX
Currency USD
Price 4.14
Market Cap 53,766,180
Dividend Yield 0%
52-week-range 3.21 - 23.52
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Scott L. Tarriff
Website https://www.eagleus.com

An error occurred while fetching data.

About Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's

Related Stocks

Coherus BioSciences, Inc. logo

Coherus BioSciences, Inc.

CHRS

1.67 USD

PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

PMVP

1.615 USD

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

3.03 USD

Inogen, Inc. logo

Inogen, Inc.

INGN

8.15 USD

Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

RANI

4.15 USD

Quanterix Corporation logo

Quanterix Corporation

QTRX

12.83 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

19.05 USD

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

0.65 USD

Financials

Numbers are in millions USD

Numbers are in millions USD